|
|
||||||||||
|
J Am Coll Cardiol, 1997; 29:1576-1584 © 1997 by the American College of Cardiology Foundation |
Department of Medicine, Columbia-Presbyterian Medical Center, New York, New York 10032, USA. djp5@columbia.edu
OBJECTIVES: The objectives of this study were to determine whether a signal-averaged electrocardiogram (SAECG) or measurement of interlead variability of QT intervals on an electrocardiogram (ECG) obtained at the time of wait-listing could provide prognostic value with respect to cardiac death during the waiting period. BACKGROUND: Because heart transplantation is a life-saving but limited resource, there remains an urgent need to identify those patients at greatest risk of dying while awaiting heart transplantation as part of the strategy to optimize the allocation of donor organs to those in greatest need. This study was undertaken to prospectively identify clinical, ECG or SAECG variables that might predict mortality during the waiting period. METHODS: Of 108 consecutive patients referred for heart transplant evaluation, 80 were placed on a waiting list, at which time a standard 12-lead ECG and a SAECG were recorded. In this cohort of 80 patients, QT dispersion was characterized from the 12-lead ECG as either the maximal-minimal QT interval (QTDISP) or as the coefficient of variation of all QT intervals (QTCV). RESULTS: During the 25-month follow-up period (mean time on waiting list, 201 days), the mortality rate was 27%/year, divided equally between heart failure and sudden deaths. No clinical variable identified at entry predicted mortality. QTDISP and QTCV were strong mortality predictors, with a 4.1-fold increase in mortality in patients with QTDISP > 140 ms compared with those patients with QTDISP < or = 140 ms (95% CI 1.1 to 14.9), whereas a QTCV > or = 9% also predicted a 4.1-fold increased risk of death (95% CI 1.4 to 11.8). Although 88% of all SAECGs were abnormal, no patient with a normal SAECG died suddenly during the waiting period. CONCLUSIONS: Indexes of QT dispersion provide a means of stratifying a patient's risk of dying while awaiting heart transplantation and may help to establish priority on a heart transplant waiting list.
This article has been cited by other articles:
![]() |
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1179 - 1199. [Full Text] [PDF] |
||||
![]() |
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention Circulation, September 30, 2008; 118(14): 1497 - 1518. [Full Text] [PDF] |
||||
![]() |
B. Vrtovec, R. Delgado, A. Zewail, C. D. Thomas, B. M. Richartz, and B. Radovancevic Prolonged QTc Interval and High B-Type Natriuretic Peptide Levels Together Predict Mortality in Patients With Advanced Heart Failure Circulation, April 8, 2003; 107(13): 1764 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Yildiz, T. Tukek, V. Akkaya, A. B. Sozen, A. Yildiz, F. Korkut, and V. Yilmaz Ventricular Arrhythmias in Patients With COPD Are Associated With QT Dispersion Chest, December 1, 2002; 122(6): 2055 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Brendorp, H. Elming, L. Jun, L. Kober, M. Malik, G. B. Jensen, and C. Torp-Pedersen QTc Interval as a Guide to Select Those Patients With Congestive Heart Failure and Reduced Left Ventricular Systolic Function Who Will Benefit From Antiarrhythmic Treatment With Dofetilide Circulation, March 13, 2001; 103(10): 1422 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Brendorp, H. Elming, L. Jun, L. Kober, M. Malik, G. B. Jensen, and C. Torp-Pedersen QT Dispersion Has No Prognostic Information for Patients With Advanced Congestive Heart Failure and Reduced Left Ventricular Systolic Function Circulation, February 13, 2001; 103(6): 831 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
J D Aitchison, R W F Campbell, and P D Higham Time dependent variability of QT dispersion after acute myocardial infarction and its relation to ventricular fibrillation: a prospective study Heart, November 1, 2000; 84(5): 504 - 508. [Abstract] [Full Text] |
||||
![]() |
P. Brooksby, P.D. Batin, J. Nolan, S.J. Lindsay, R. Andrews, M. Mullen, W. Baig, A.D. Flapan, R.J. Prescott, J.M.M. Neilson, et al. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART) Eur. Heart J., September 2, 1999; 20(18): 1335 - 1341. [Abstract] [PDF] |
||||
![]() |
I. LORINCZ, J. MÁTYUS, Z. ZILAHI, C. KUN, Z. KARÁNYI, and G. KAKUK QT Dispersion in Patients with End-Stage Renal Failure and during Hemodialysis J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1297 - 1302. [Abstract] [Full Text] |
||||
![]() |
M. Zabel, T. Klingenheben, M. R. Franz, and S. H. Hohnloser Assessment of QT Dispersion for Prediction of Mortality or Arrhythmic Events After Myocardial Infarction : Results of a Prospective, Long-term Follow-up Study Circulation, June 30, 1998; 97(25): 2543 - 2550. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |